ALX Oncology Holdings Inc.ALXONASDAQ
Loading
Interest Expense Over TimeStrong
Percentile Rank86
3Y CAGR+88.8%
5Y CAGR+14.6%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
+88.8%/yr
Annual compound
5Y CAGR
+14.6%/yr
Recent acceleration
Percentile
P86
Within normal range
vs 5Y Ago
2x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$1.60M-7.3%
2024$1.73M+10.5%
2023$1.56M+557.6%
2022$238000.00+1730.8%
2021$13000.00-98.4%
2020$811000.00+3761.9%
2019$21000.00-
2018$0.00-